Press release from Companies

Publicerat: 2025-10-14 10:01:00

PolarCool AB: Swedish Champions Ystads IF Handball Extend Agreement for PolarCap®

Med-tech company PolarCool AB (publ.) announces that it has extended its agreement with Ystads IF Handball for the use of PolarCap® for an additional 1 year. The club has successfully integrated treatment with PolarCap® into its concussion management routines over the past four seasons.

PolarCool develops and markets PolarCap®, a medical device that enhances recovery following a concussion through controlled cooling treatment. The product is primarily used in sports with an elevated risk of head injuries, such as ice hockey, rugby, football, and handball.

PolarCool CEO Erik Andersson comments:

-I am pleased to see that many of our long-term customers, such as Ystads IF Handball, who have been using PolarCap® for several years, choose to continue. This demonstrates trust and serves as confirmation of PolarCap®’s clinically proven positive effects.

The contract extension with Ystads IF Handball is an important step toward PolarCool’s goal of increasing its presence in the European handball market, giving the agreement significant strategic value.

For more information

Erik Andersson –  CEO PolarCool AB (publ.)               
+46 - 738 60 57 00                                         
E-mail:
erik.andersson@polarcool.se

About PolarCool AB (publ.)

PolarCool AB (publ.) is a Swedish medical technology company focused on developing and marketing products in the sports medicine field. Its primary product, PolarCap®, is designed to reduce the impact of concussion through targeted brain cooling. PolarCool works with professional teams across Europe in rugby, football, and ice hockey and it shares are listed on Spotlight Stock Market.

Läs mer hos Cision
Läs mer om PolarCool AB